Arbutus Biopharma Corpora... (ABUS)
NASDAQ: ABUS
· Real-Time Price · USD
3.33
-0.04 (-1.19%)
At close: Aug 15, 2025, 3:59 PM
3.37
1.01%
After-hours: Aug 15, 2025, 05:47 PM EDT
Arbutus Biopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 15.42M | 6.4M | 6.17M | 6.74M | 10.06M | 12.99M | 18.14M | 22.24M | 23.54M | 33.13M | 39.02M | 35.98M | 33.37M | 21.46M | 10.99M | 10.17M | 8.35M | 7.54M |
Cost of Revenue | 9.3M | 9.65M | 16.09M | 16.12M | 16.49M | 16.47M | 1.4M | 1.35M | 1.33M | 1.37M | 1.43M | 1.55M | 17.91M | 33.33M | 46.72M | 60.83M | 56.18M | 50.85M |
Gross Profit | 6.11M | -3.25M | 5.13M | 5.67M | 8.62M | 11.56M | 16.74M | 20.89M | 22.21M | 31.76M | 37.59M | 34.43M | 15.46M | -11.87M | -35.73M | -50.66M | -47.83M | -43.31M |
Operating Income | -68.12M | -91.4M | -75.93M | -82.52M | -82.63M | -79.65M | -77.88M | -79.92M | -76.17M | -71.89M | -65.46M | -63.69M | -64.29M | -68.82M | -73.52M | -69.03M | -65.84M | -60.34M |
Interest Income | 5.45M | 6.24M | 6.58M | 6.59M | 6.33M | 5.96M | 5.69M | 5.17M | 4.37M | 3.3M | 2.19M | 1.28M | 612K | 247K | 127K | 193K | 266K | 435K |
Pretax Income | -54.25M | -76.57M | -69.92M | -76.7M | -77.09M | -74.39M | -72.85M | -75.47M | -72.93M | -70.03M | -65.01M | -64.4M | -65.99M | -71.19M | -76.25M | -71.97M | -71.56M | -66.27M |
Net Income | -54.25M | -76.57M | -69.92M | -76.7M | -77.09M | -74.39M | -71.97M | -75.57M | -72.79M | -69.97M | -70.27M | -68.68M | -70.52M | -75.63M | -76.25M | -71.97M | -71.56M | -66.27M |
Selling & General & Admin | 18.4M | 22.27M | 21.4M | 21.43M | 22.73M | 21.52M | 22.12M | 21.62M | 19.27M | 18.49M | 17.83M | 18.28M | 18.94M | 18.18M | 17.14M | 15.98M | 15.9M | 15.02M |
Research & Development | 37.54M | 47.59M | 54.04M | 62.79M | 68.69M | 70.83M | 73.7M | 79.08M | 78.97M | 84.22M | 84.41M | 81.9M | 78.14M | 70.59M | 65.5M | 59.6M | 55.37M | 50.44M |
Other Expenses | 18.63M | 18.84M | 6.34M | 4.36M | 596K | 385K | 478K | 2.5M | 2.51M | 2.71M | 2.64M | -702K | -470K | -242K | n/a | 1.81M | 1.86M | 1.92M |
Operating Expenses | 74.56M | 88.49M | 81.39M | 88.19M | 91.62M | 92.55M | 96.02M | 100.91M | 98.25M | 102.72M | 102.24M | 98.85M | 96.2M | 88.33M | 82.64M | 77.39M | 73.12M | 67.37M |
Interest Expense | 115K | 121K | 137K | 151K | 168K | 305K | 459K | 724K | 1.11M | 1.42M | 1.73M | 1.98M | 2.31M | 2.59M | 2.86M | 3.09M | 3.41M | 3.74M |
Selling & Marketing Expenses | n/a | -356K | -711K | -1.07M | -1.07M | -714K | -359K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 83.53M | 97.81M | 82.1M | 89.26M | 92.69M | 93.27M | 96.38M | 100.91M | 98.25M | 102.72M | 102.24M | 98.85M | 96.2M | 88.33M | 82.64M | 77.39M | 73.12M | 67.37M |
Income Tax Expense | n/a | n/a | n/a | 1.07M | 1.07M | 1.25M | 369K | 274K | 30K | -58K | 5.26M | 4.28M | 4.53M | 4.44M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 191.55M | 190.71M | 185.61M | 189M | 188.04M | 175.63M | 168.44M | 167.51M | 166.06M | 161.64M | 154.42M | 151M | 148.75M | 143.32M | 101.29M | 101.02M | 96.87M | 93.43M |
Shares Outstanding (Diluted) | 192.4M | 190.71M | 189.96M | 189M | 188.04M | 175.63M | 168.44M | 167.51M | 166.06M | 161.64M | 154.42M | 151M | 148.75M | 148.43M | 101.29M | 101.29M | 96.87M | 93.43M |
EPS (Basic) | -0.28 | -0.41 | -0.38 | -0.42 | -0.44 | -0.43 | -0.43 | -0.47 | -0.46 | -0.45 | -0.47 | -0.53 | -0.61 | -0.71 | -0.78 | -0.75 | -0.8 | -0.8 |
EPS (Diluted) | -0.28 | -0.41 | -0.38 | -0.42 | -0.44 | -0.43 | -0.43 | -0.47 | -0.46 | -0.45 | -0.47 | -0.53 | -0.61 | -0.71 | -0.78 | -0.75 | -0.8 | -0.8 |
EBITDA | -53.12M | -75.09M | -68.4M | -75.14M | -75.48M | -72.66M | -70.99M | -73.39M | -70.5M | -67.25M | -61.86M | -60.88M | -62.03M | -66.89M | -71.64M | -67.06M | -66.3M | -60.6M |
EBIT | -54.14M | -76.45M | -69.78M | -76.55M | -76.92M | -74.08M | -72.39M | -74.75M | -71.83M | -68.61M | -63.29M | -62.42M | -63.68M | -68.6M | -73.39M | -68.87M | -65.61M | -59.98M |
Depreciation & Amortization | 1.01M | 1.36M | 1.38M | 1.41M | 1.44M | 1.43M | 1.4M | 1.35M | 1.33M | 1.37M | 1.43M | 1.55M | 1.65M | 1.7M | 1.75M | 1.81M | 1.86M | 1.92M |